THERAPEUTIC INTERVENTIONS FOR A-T: Part 2 - A-T: Scientific and Medical Information

Featured

THERAPEUTIC INTERVENTIONS FOR A-T: Part 2

An A-T Clinical Research Conference Zoom Session

Come Learn About A-T Trials That Have Data To Share!

10.00 AM EST: Welcome and introductions by Cynthia Rothblum-Oviatt
10.05: David Coman: Triheptanoin - A trial in progress for A-T (recorded presentation)
10.20: Discussion (note this will not be Q&A style)
10.30: David Lynch: Omaveloxolone - Presentation of findings with Friedreich’s ataxia and
insights on clinical trial design for rare diseases
10.55 Q&A and Discussion
11.10: Helena Donath: Potential biomarkers for A-T – NF-L and miRNA
11.25: Q&A and Discussion
11.35: Howard Lederman: Finding biomarkers for A-T – potential for an in-depth session
11.50: General discussion - Biomarkers
12.00: Last minute Q&A / Discussion for all speakers
12.30: Adjourn

Programme Therapeutic Interventions A-T Part 2

Save-the-Date

Thursday, December 9, 2021 at 7AM PT US/ 10AM ET US/

3PM UK / 4 PM EU

Session to last approx. 2.5h

Registration Information

https://us06web.zoom.us/meeting/register/tZwpduiurDopGNIrmQnQC5c12A3HOC860Bi7

After registering, you will receive a confirmation email containing information about joining the meeting. If you have any registration questions, please contact Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. with the A-T Society.

A-TCRN Questions? Contact

Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo. | Este endereço de email está sendo protegido de spambots. Você precisa do JavaScript ativado para vê-lo.